日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Xeno interactions between MHC-I proteins and molecular chaperones enable ligand exchange on a broad repertoire of HLA allotypes

MHC-I蛋白与分子伴侣之间的异种相互作用能够实现多种HLA同种异型配体的配体交换。

Yi Sun ,Georgia F Papadaki ,Christine A Devlin ,Julia N Danon ,Michael C Young ,Trenton J Winters ,George M Burslem ,Erik Procko ,Nikolaos G Sgourakis

A computationally designed ACE2 decoy has broad efficacy against SARS-CoV-2 omicron variants and related viruses in vitro and in vivo

通过计算设计的 ACE2 诱饵在体内和体外对 SARS-CoV-2 omicron 变体和相关病毒具有广泛的功效

Brandon Havranek, Graeme Walker Lindsey, Yusuke Higuchi, Yumi Itoh, Tatsuya Suzuki, Toru Okamoto, Atsushi Hoshino, Erik Procko, Shahidul M Islam0

The Sequence Basis for Selectivity of Ephrin-B2 Ligand for Eph Receptors and Pathogenic Henipavirus G Glycoproteins: Selective Ephrin-B2 Decoys for Nipah and Hendra Virus

Ephrin-B2 配体对 Eph 受体和致病性亨尼帕病毒 G 糖蛋白的选择性序列基础:针对尼帕病毒和亨德拉病毒的选择性 Ephrin-B2 诱饵

Krishna K Narayanan, Moushimi Amaya, Natalie Tsang, Randy Yin, Alka Jays, Christopher C Broder, Diwakar Shukla, Erik Procko

TAPBPR employs a ligand-independent docking mechanism to chaperone MR1 molecules

TAPBPR 采用不依赖配体的对接机制来陪伴 MR1 分子

Andrew C McShan, Christine A Devlin, Georgia F Papadaki, Yi Sun, Adam I Green, Giora I Morozov, George M Burslem, Erik Procko, Nikolaos G Sgourakis

Engineered ACE2 decoy mitigates lung injury and death induced by SARS-CoV-2 variants

经过改造的 ACE2 诱饵可减轻 SARS-CoV-2 变体引起的肺损伤和死亡

Lianghui Zhang, Soumajit Dutta #, Shiqin Xiong #, Matthew Chan #, Kui K Chan, Timothy M Fan, Keith L Bailey, Matthew Lindeblad, Laura M Cooper, Lijun Rong, Anthony F Gugliuzza, Diwakar Shukla, Erik Procko, Jalees Rehman, Asrar B Malik

An ACE2 decoy can be administered by inhalation and potently targets omicron variants of SARS-CoV-2

ACE2 诱饵可通过吸入方式给药,可有效针对 SARS-CoV-2 的 omicron 变体

Lianghui Zhang, Krishna K Narayanan #, Laura Cooper #, Kui K Chan, Savanna S Skeeters, Christine A Devlin, Aaron Aguhob, Kristie Shirley, Lijun Rong, Jalees Rehman, Asrar B Malik, Erik Procko

An engineered ACE2 decoy receptor can be administered by inhalation and potently targets the BA.1 and BA.2 omicron variants of SARS-CoV-2

经过改造的 ACE2 诱饵受体可通过吸入方式给药,并有效针对 SARS-CoV-2 的 BA.1 和 BA.2 omicron 变体

Lianghui Zhang, Krishna K Narayanan, Laura Cooper, Kui K Chan, Christine A Devlin, Aaron Aguhob, Kristie Shirley, Lijun Rong, Jalees Rehman, Asrar B Malik, Erik Procko

TAPBPR promotes antigen loading on MHC-I molecules using a peptide trap

TAPBPR利用肽陷阱促进抗原加载到MHC-I分子上。

Andrew C McShan # ,Christine A Devlin # ,Giora I Morozov ,Sarah A Overall ,Danai Moschidi ,Neha Akella ,Erik Procko ,Nikolaos G Sgourakis

Engineered High-Affinity ACE2 Peptide Mitigates ARDS and Death Induced by Multiple SARS-CoV-2 Variants

工程化高亲和力 ACE2 肽可缓解多种 SARS-CoV-2 变体引起的 ARDS 和死亡

Lianghui Zhang, Soumajit Dutta, Shiqin Xiong, Matthew Chan, Kui K Chan, Timothy M Fan, Keith L Bailey, Matthew Lindeblad, Laura M Cooper, Lijun Rong, Anthony F Gugliuzza, Diwakar Shukla, Erik Procko, Jalees Rehman, Asrar B Malik

Engineered receptors for human cytomegalovirus that are orthogonal to normal human biology

与正常人类生物学正交的人类巨细胞病毒受体

Jihye Park, Kevin Sean Gill, Ali Asghar Aghajani, Jeremiah Dallas Heredia, Hannah Choi, Adam Oberstein, Erik Procko